Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    Conference Program for 2022 the World Conference on Lung Cancer

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2137

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      EP08.01-030 - Nivolumab+Ipilimumab Vs Platinum-Based CT+Nivolumab In Advanced Lung Squamous-Cell Carcinoma: The Randomized SQUINT Trial

      Presenter: Federico Cappuzzo

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-048 - Crizotinib in ROS1+NSCLC: Long-term OS Analysis in Patients with Brain Metastases Included in the Phase II METROS Trial

      Presenter: Federico Cappuzzo

      • Abstract

      Loading...

  • +

    EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      EP16.03-040 - Biomarkersatlas.com: the Italian NSCLC Precision Medicine Knowledge Data Base

      Presenter: Umberto Malapelle

      • Abstract

      Loading...

  • +

    IS22 - Industry Symposium Sponsored by Sanofi Regeneron: Breaking Barriers with Immunotherapy in Squamous Cell Carcinoma of the Lung: Challenges and Opportunities in Management

    • 13:30 - 14:30
    • 8/08/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Industry Symposium
    • Track: N/A
    • +

      Session Moderator

      13:30 - 13:30  |  Presenter: Federico Cappuzzo

      • Abstract

      Loading...

    • +

      IS22.01 - Welcome and Introduction

      13:30 - 13:35  |  Presenter: Federico Cappuzzo

      • Abstract

      Loading...

  • +

    P2.14 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      P2.14-02 - TP53 Mutations Affect Sensitivity to Lorlatinib in ROS1 Positive NSCLC: Final Results of the PFROST Trial

      Presenter: Lorenza Landi

      • Abstract

      Loading...

  • +

    ES28 - Neoadjuvant and Adjuvant Treatment of NSCLC in 2022

    • 10:45 - 11:45
    • 8/09/2022
    • Location: Hall C1
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Early Stage Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Systemic Therapy (Multi-Modality Treatment, Immunotherapy, Molecular Targeted Treatments)
    • +

      ES28.05 - How Does MRD Status Affect Decisions on Adjuvant Therapy?

      11:11 - 11:23  |  Presenter: Federico Cappuzzo

      • Abstract

      Loading...